Stay updated with breaking news from Eric Venker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 33,081 shares of the stock in a transaction on Monday, July 24th. The stock was sold at an average price of $10.93, for a total value of $361,575.33. Following the transaction, the chief operating officer now directly owns 644,215 shares in the company, […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 181,998 shares of the business’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $11.13, for a total value of $2,025,637.74. Following the sale, the chief operating officer now directly owns 644,215 shares of the […]
Truist Financial reaffirmed their buy rating on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a report published on Friday morning, Benzinga reports. The brokerage currently has a $23.00 price objective on the stock. Several other equities analysts have also commented on the stock. HC Wainwright increased their price target on shares of Roivant […]
Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) has been given a consensus recommendation of “Moderate Buy” by the seven brokerages that are covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1 year price objective among analysts […]
Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) hit a new 52-week high during trading on Thursday . The stock traded as high as $11.69 and last traded at $10.86, with a volume of 7779219 shares trading hands. The stock had previously closed at $10.63. Analyst Upgrades and Downgrades A number of equities analysts […]